Nevro Corp. stock is up 20.1% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 9 November’s closed higher than October. In the last 4 Unusual Options Trades, there were 4 PUTs. 0% of analysts rate it a buy.
Nevro Corp. provides products for patients suffering from chronic pain in the United States and internationally. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro was incorporated in 2006 and is headquartered in Redwood City, California.